Harrison and his team have pushed forward with a trial of the nasal insulin vaccine believing they are on the path to prevent the autoimmune destruction of beta cells...
Tag: Diabetes Vaccine
Diamyd Medical announced it has completed the screening of patients for the US Phase III study, DiaPrevent, ending the recruitment campaign.
More than 310 recently diagnosed type 1 diabetes patients between 10 and 20 years of age have already been enrolled in the study and have received their first injection of the antigen-based therapy Diamyd or placebo...
Diamyd Medical announced the Food and Drug Administration (FDA) granted its type 1 diabetes drug candidate Diamyd® Orphan Drug Designation.
Orphan drugs qualify for several incentives including a seven-year period of market exclusivity in the US...
Diamyd Medical AB, a Swedish diabetes company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, announced it plans to file the Diamyd® diabetes vaccine for market approval in 2011...